Your browser doesn't support javascript.
loading
Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane.
Zhou, X Edward; Suino-Powell, Kelly; Schultz, Chad R; Aleiwi, Bilal; Brunzelle, Joseph S; Lamp, Jared; Vega, Irving E; Ellsworth, Edmund; Bachmann, André S; Melcher, Karsten.
Afiliação
  • Zhou XE; Department of Structural Biology, Van Andel Institute, Grand Rapids, Michigan 49503, U.S.A.
  • Suino-Powell K; Department of Structural Biology, Van Andel Institute, Grand Rapids, Michigan 49503, U.S.A.
  • Schultz CR; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI 49546, U.S.A.
  • Aleiwi B; Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI 48824, U.S.A.
  • Brunzelle JS; Northwestern University Synchrotron Research Center, Life Sciences Collaborative Access Team, Northwestern University, Argonne, Illinois 60439, U.S.A.
  • Lamp J; Department of Translational Neuroscience, Integrated Mass Spectrometry Unit, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, U.S.A.
  • Vega IE; Department of Translational Neuroscience, Integrated Mass Spectrometry Unit, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, U.S.A.
  • Ellsworth E; Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI 48824, U.S.A.
  • Bachmann AS; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI 49546, U.S.A.
  • Melcher K; Department of Structural Biology, Van Andel Institute, Grand Rapids, Michigan 49503, U.S.A.
Biochem J ; 478(23): 4137-4149, 2021 12 10.
Article em En | MEDLINE | ID: mdl-34796899
ABSTRACT
Ornithine decarboxylase (ODC) is the rate-limiting enzyme for the synthesis of polyamines (PAs). PAs are oncometabolites that are required for proliferation, and pharmaceutical ODC inhibition is pursued for the treatment of hyperproliferative diseases, including cancer and infectious diseases. The most potent ODC inhibitor is 1-amino-oxy-3-aminopropane (APA). A previous crystal structure of an ODC-APA complex indicated that APA non-covalently binds ODC and its cofactor pyridoxal 5-phosphate (PLP) and functions by competing with the ODC substrate ornithine for binding to the catalytic site. We have revisited the mechanism of APA binding and ODC inhibition through a new crystal structure of APA-bound ODC, which we solved at 2.49 Šresolution. The structure unambiguously shows the presence of a covalent oxime between APA and PLP in the catalytic site, which we confirmed in solution by mass spectrometry. The stable oxime makes extensive interactions with ODC but cannot be catabolized, explaining APA's high potency in ODC inhibition. In addition, we solved an ODC/PLP complex structure with citrate bound at the substrate-binding pocket. These two structures provide new structural scaffolds for developing more efficient pharmaceutical ODC inhibitors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ornitina Descarboxilase / Propilaminas / Inibidores da Ornitina Descarboxilase Limite: Humans Idioma: En Revista: Biochem J Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ornitina Descarboxilase / Propilaminas / Inibidores da Ornitina Descarboxilase Limite: Humans Idioma: En Revista: Biochem J Ano de publicação: 2021 Tipo de documento: Article